REG - CVS Group plc - Director/PDMR Shareholding

CVSAnnouncement

02/06/2025 13:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250602:nRSB0529La&default-theme=true

RNS Number : 0529L  CVS Group plc  02 June 2025

2 June 2025

 

CVS Group plc

 

("CVS" or the "Company")

 

PDMR Dealing

CVS, the UK's listed veterinary group and a leading provider of veterinary
services, announces that it was notified on 2 June 2025 that David Wilton,
Non-executive Chairman of the Company, purchased a total of 1,000 ordinary
shares of 0.2p each in the Company ("Ordinary Shares") on the same date.

As a result, David Wilton's total interest in the Company, including all
persons closely associated, is now 10,000 Ordinary Shares, representing 0.014%
per cent of the total voting rights of the Company.

The notification below, made in accordance with the requirements of the UK
Market Abuse Regulation, provides further detail.

Contacts:

CVS Group plc
 
            via Camarco

Richard Fairman, CEO

Scott Morrison, Company Secretary

 

Peel Hunt LLP (Nominated Adviser & Broker)
                                +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark

 

   Berenberg (Joint Broker)
 
   +44 (0)20 3207 7800

Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser

 

Camarco (Financial
PR)

Geoffrey Pelham-Lane
 
      +44 (0)7733 124 226

Ginny Pulbrook
 
              +44 (0)7961 315 138

 

 

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them

 1    Details of the person discharging managerial responsibilities / person closely

    associated

 a)   Name                                                         David Wilton

 2    Reason for the notification

 a)   Position/status                                              PDMR (Chairman)

 b)   Initial notification /Amendment                              Initial Notification

 3    Details of the issuer, emission allowance market participant, auction

    platform, auctioneer or auction monitor

 a)   Name                                                         CVS Group plc

 b)   LEI                                                          213800J41XDQ2NX48O05

 4    Details of the transaction(s): section to be repeated for (i) each type of

    instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument  Ordinary shares of 0.2 pence each

      Identification code

                                                                   GB00B2863827

 b)   Nature of the transaction                                    On-market purchase

 c)   Price(s) and volume(s)

Price(s) - pence  Volume(s)

                                                                   1,247.60          1,000
 d)   Aggregated information

                                                                   N/A - single transaction

      - Aggregated volume

      - Price

 e)   Date of the transaction                                      2 June 2025

 f)   Place of the transaction                                     London Stock Exchange - AIM (XLON)

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

N/A - single transaction

e)

 

Date of the transaction

 

 

2 June 2025

f)

 

Place of the transaction

 

London Stock Exchange - AIM (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHEAFKAESLSEFA